The pharmacology and therapeutic applications of monoclonal antibodies
Abstract Monoclonal antibodies (mAbs) have emerged as a major class of therapeutic agents on the market. To date, approximately 80 mAbs have been granted marketing approval. In 2018, 12 new mAbs were approved by the FDA, representing 20% of the total number of approved drugs. The majority of mAb the...
Saved in:
Main Authors: | María Sofía Castelli (Author), Paul McGonigle (Author), Pamela J. Hornby (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monoclonal Antibodies as Neurological Therapeutics
by: Panagiotis Gklinos, et al.
Published: (2021) -
Volcanic Plumes.Impacts on the Atmosphere and Insights into Volcanic Processes
by: McGonigle, Andrew
Published: (2019) -
Genomic Citizenship The Molecularization of Identity in the Contemporary Middle East
by: McGonigle, Ian
Published: (2021) -
Monoclonal antibodies as potent therapeutics in dentistry.
by: Pratichi Tripathi, et al.
Published: (2019) -
Advances and challenges in therapeutic monoclonal antibodies drug development
by: Mariana Lopes dos Santos, et al.
Published: (2018)